Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	691
Journal	European Journal of Heart Failure
Volume	19
Issue number	5
DOIs	https://doi.org/10.1002/ejhf.753
Publication status	Published - May 1 2017

Cite this

@article{260a70f657c342bd8b8cfa379520e9a5,

title = "Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation",

author = "Marco Guazzi",

year = "2017",

month = may,

day = "1",

doi = "10.1002/ejhf.753",

language = "English",

volume = "19",

pages = "691",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "John Wiley & Sons, Ltd",

number = "5",

}

TY - JOUR

T1 - Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation

AU - Guazzi, Marco

PY - 2017/5/1

Y1 - 2017/5/1

UR - http://www.scopus.com/inward/record.url?scp=85011117665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011117665&partnerID=8YFLogxK

U2 - 10.1002/ejhf.753

DO - 10.1002/ejhf.753

M3 - Letter

AN - SCOPUS:85011117665

VL - 19

SP - 691

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

IS - 5

ER -